Commentary on A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines
Dermatol Surg
.
2021 Jan 1;47(1):47.
doi: 10.1097/DSS.0000000000002563.
Author
Amelia K Hausauer
1
Affiliation
1
AESTHETX Plastic Surgery and Dermatology, Campbell, California.
PMID:
32796331
DOI:
10.1097/DSS.0000000000002563
No abstract available
Publication types
Comment
MeSH terms
Botulinum Toxins, Type A*
Humans
Neuromuscular Agents*
Substances
Neuromuscular Agents
Botulinum Toxins, Type A